COCRYSTAL PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure

On January 21, 2021, Dr. Sam Lee, President of Cocrystal Pharma, Inc. (the "Company") will be making a presentation at the virtual 3rd Annual reimagine Health Research Symposium being held at the University of Arizona College of Medicine. A copy of the Company's presentation to be used at this symposium is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The presentation is also available on the Company's website at www.cocrystalpharma.com.

The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits



Exhibit   Description

99.1        Cocrystal Pharma, Inc. Presentation, dated January 21, 2021

© Edgar Online, source Glimpses